We receive funding from a variety of sources that recognize the value of our high-impact research.
Supriya Mahajan, PhD, MPH
- Inhibition of Radiation-Induced Coronary Microvascular Disease. Supriya Mahajan (Co-Investigator). NIH. $1,750,000. 9/1/2020-8/1/2025.
- Biomarkers for Type III Hereditary Angioedema. Supriya Mahajan (Co-Investigator). Takeda originally Shire. $275,000. 1/1/2018-12/1/2023.
- Recognizing Excellence Program. Supriya Mahajan (Principal Investigator). Office of the Vice Provost for Faculty Affairs UB. $7,500. 9/1/2026-9/1/2028.
- Research, Innovation and Economic Development Grant Resubmission Program. Supriya Mahajan (Principal Investigator). UB's VPR office. $15,000. 9/1/2026-8/1/2027.
- Quantum AI Modeling of BBB Transport and Neuroinflammation. Supriya Mahajan (Principal Investigator). SUNY- SUNY AI Platform project. $50,000. 11/1/2026-5/1/2027.
Jessica Reynolds, PhD
- Initiative for Maximizing Student Development at University at Buffalo. Jessica Reynolds (Co-Investigator). NGMS. 12/1/2021-1/1/2027.
- Sustained release of luzindole. Jessica Reynolds (Co-Principal Investigator). UB. 3/1/2023-1/1/2024.
- Buffalo Clinical and Translational Research Center. Jessica Reynolds (Co-Investigator). NIH. 9/1/2019-1/1/2024.
Stanley Schwartz, MD, PhD
- A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cance. Stanley Schwartz (Principal Investigator). Department of Veterans Affairs. 1/1/2022-12/1/2025.